More tools:
Markets
·
Screener
·
Research
·
Chat
BIOSTEM TECHNOLOGIES NEW (BSEM) Financial Statements
BIOSTEM TECHNOLOGIES NEW
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG001SC0G68
OTC Link · usd
4.21
▲ 0.21 (5.25%)
As of 2026-09-09
1M
6M
1Y
Valuation
Market Cap
$75.1M
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
—
EBITDA
—
Diluted EPS (TTM)
—
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
4.00
Day's Range
4.04 – 4.30
52-Week Range
2.25 – 8.40
Volume
117.6K
Avg Volume
120.6K
Share Statistics
Shares Outstanding
17.8M
Employees
—
Exchange
OTC Link
Listed
—
Share count as of August 12, 2026
View
Income Statement
Balance Sheet
Cash Flow
Key Metrics
Valuation
Comparable Companies
Notes & Facts
DCF Model
Earnings Calls
Guidance
Presentations
Detail
Standard
Detailed
Period
Annual
Quarterly
TTM
Loading Income Statement…
Key questions about BIOSTEM TECHNOLOGIES NEW (BSEM)
What is BIOSTEM TECHNOLOGIES NEW's Market Cap?
BIOSTEM TECHNOLOGIES NEW's Market Cap is $75.1M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Subscribe
Income Statement
(in thousands of USD, except per-share data)
Source: Akyla.ai
Line Item
Jun 30, 2026
Jun 30, 2025
Revenue
7,899.2
Cost of goods sold
3,058.6
Gross profit
4,840.7
% of revenue
61.3%
Sales and marketing
5,321.9
General and administrative
6,496.5
Research and development
733.6
Depreciation and amortization
689.3
Total operating expenses
13,241.3
% of revenue
167.6%
(Loss) income from operations
(8,400.7)
% of revenue
-106.3%
Other (expense) income
Interest income, net
23.4
Other (expense) income
(594.0)
Other (expense) income, net
(570.7)
Total (loss) income from operations before income taxes
(8,971.4)
Income tax expense
0.0
Net (loss) income
(8,971.4)
% of revenue
-113.6%
Basic (loss) income per common share
(0.52)
Diluted (loss) income per common share
(0.52)